Dr. Cynthia A. Maryanoff Distinguished Research Fellow, Pharmaceutical Development Cordis, A Johnson and Johnson Company 4:30 PM, Jenkins Lecture Hall (Mendel 101) Tuesday January 22, 2008

Active Pharmaceutical Ingredients [APIs] are the key ingredient of medicines. The discovery of biological activity of a chemical to the development of an API can in rare cases lead to marketing of a medicine. What is the path required? Why does it take so long for a compound to advance from discovery through development to approval by regulatory authorities? What is the outlook for the 21st century? Dr. Cynthia Maryanoff will share her perspective of the golden age of pharmaceuticals.